Please provide your email address to receive an email when new articles are posted on . Isolated ACL reconstruction had a graft failure rate of 10% vs. 4% in ACL plus anterolateral ligament ...
ABANZA’s QuadLock™ delivers market-leading fixation strength with over a 500% reduction in cyclic displacement compared to conventional fixation methods. QuadLock™ is designed to securely fixate ...
Please provide your email address to receive an email when new articles are posted on . Results showed no significant differences in retear rates between patients with vs. those without tendinopathy.
At second-look arthroscopies, Shino et al [8] detected deterioration of the patellofemoral articular surface. Fifty-one percent were noted to have progressive arthrosis primarily affecting the central ...
ABANZA, a company focused on next-generation soft-tissue repair solutions, today announced that the U.S. Food and Drug Administration (FDA) has granted 510(k) clearance for QuadLock(TM), its new ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results